subject	subject_entity	predicate	object	object_entity	doc_id	doc_filename
Mutations	genetic variant	cause	Inherited Disorder of the Endoplasmic Reticulum-Associated Degradation	disease	PMC4243708	PMC4243708.txt
NGLY1	gene	has gene product	Mutations	genetic variant	PMC4243708	PMC4243708.txt
ERAD pathway	pathway	responsible for	translocation of misfolded proteins	biological process	PMC4243708	PMC4243708.txt
ERAD pathway	pathway	has participant	proteasome	molecular activity	PMC4243708	PMC4243708.txt
N-glycanase 1	protein	involved in	ERAD pathway	pathway	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	movement disorder	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	hypotonia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	hypo- or alacrima	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	microcephaly	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	diminished reflexes	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	hepatocyte cytoplasmic storage material or vacuolization	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	seizures	phenotype	PMC4243708	PMC4243708.txt
c.1201A>T (p.R401X)	genetic variant	is allele of	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	neurological dysfunction	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	abnormal tear production	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	liver disease	disease	PMC4243708	PMC4243708.txt
c.1201A>T (p.R401X)	genetic variant	associated with	severe disease	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	alacrima	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	choreoathetosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	seizures	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	liver disease	phenotype	PMC4243708	PMC4243708.txt
N-glycanase 1	protein	also known as	peptide:N-glycanase	protein	PMC4243708	PMC4243708.txt
N-glycanase 1	protein	catalyzes	protein deglycosylation	biological process	PMC4243708	PMC4243708.txt
N-glycanase 1	protein	participates in	endoplasmic reticulum-associated degradation	pathway	PMC4243708	PMC4243708.txt
N-glycanase 1	protein	interacts with	AAA ATPase complex p97	macromolecular complex	PMC4243708	PMC4243708.txt
endoplasmic reticulum-associated degradation	pathway	involved in	degrading misfolded glycoproteins	biological process	PMC4243708	PMC4243708.txt
N-glycans	macromolecular complex	has role	quality control tags for proteins	biological process	PMC4243708	PMC4243708.txt
Misfolded glycoproteins	protein	detected by	ER luminal lectins	protein	PMC4243708	PMC4243708.txt
Misfolded glycoproteins	protein	translocated to	the cytosol	cellular component	PMC4243708	PMC4243708.txt
Misfolded glycoproteins	protein	degraded by	cytosolic enzymes	protein	PMC4243708	PMC4243708.txt
cytosolic enzymes	protein	includes	NGLY1	protein	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	caused by	mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	ERAD process	biological process	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	congenital disorder of glycosylation	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	accumulation of an amorphous unidentified substance	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	abnormal accumulation of misfolded glycoproteins	phenotype	PMC4243708	PMC4243708.txt
NGLY1	gene	produces	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
NGLY1	gene	has role	impaired cytosolic degradation	molecular activity	PMC4243708	PMC4243708.txt
Liver biopsy	assay	produces	accumulation of an amorphous unidentified substance	phenotype	PMC4243708	PMC4243708.txt
Liver biopsy	assay	produces	abnormal accumulation of misfolded glycoproteins	phenotype	PMC4243708	PMC4243708.txt
Liver biopsy	assay	located in	cytoplasm	cellular component	PMC4243708	PMC4243708.txt
mutations in NGLY1	genetic variant	causes	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
mutations in NGLY1	genetic variant	causes	impaired cytosolic degradation	molecular activity	PMC4243708	PMC4243708.txt
mutations in NGLY1	genetic variant	causes	abnormal accumulation of misfolded glycoproteins	phenotype	PMC4243708	PMC4243708.txt
mutations in NGLY1	genetic variant	causes	accumulation of an amorphous unidentified substance	phenotype	PMC4243708	PMC4243708.txt
mutations in NGLY1	genetic variant	causes	congenital disorder of glycosylation	phenotype	PMC4243708	PMC4243708.txt
ERAD process	biological process	associated with	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
ERAD process	biological process	has participant	NGLY1	gene	PMC4243708	PMC4243708.txt
ERAD process	biological process	has participant	mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
ERAD process	biological process	has participant	impaired cytosolic degradation	molecular activity	PMC4243708	PMC4243708.txt
ERAD process	biological process	has participant	abnormal accumulation of misfolded glycoproteins	phenotype	PMC4243708	PMC4243708.txt
ERAD process	biological process	has participant	accumulation of an amorphous unidentified substance	phenotype	PMC4243708	PMC4243708.txt
ERAD process	biological process	has participant	congenital disorder of glycosylation	phenotype	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	Liver biopsy	assay	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	accumulation of an amorphous unidentified substance	phenotype	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	abnormal accumulation of misfolded glycoproteins	phenotype	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	impaired cytosolic degradation	molecular activity	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	NGLY1	gene	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	ERAD process	biological process	PMC4243708	PMC4243708.txt
cytoplasm	cellular component	location of	congenital disorder of glycosylation	phenotype	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	caused by	mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	caused by	NGLY1	gene	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	causes	abnormal accumulation of misfolded glycoproteins	phenotype	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	causes	accumulation of an amorphous unidentified substance	phenotype	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	causes	congenital disorder of glycosylation	phenotype	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	part of	ERAD process	biological process	PMC4243708	PMC4243708.txt
impaired cytosolic degradation	molecular activity	located in	cytoplasm	cellular component	PMC4243708	PMC4243708.txt
abnormal accumulation of misfolded glycoproteins	phenotype	caused by	mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
abnormal accumulation of misfolded glycoproteins	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
abnormal accumulation of misfolded glycoproteins	phenotype	caused by	NGLY1	gene	PMC4243708	PMC4243708.txt
abnormal accumulation of misfolded glycoproteins	phenotype	caused by	impaired cytosolic degradation	molecular activity	PMC4243708	PMC4243708.txt
abnormal accumulation of misfolded glycoproteins	phenotype	part of	ERAD process	biological process	PMC4243708	PMC4243708.txt
abnormal accumulation of misfolded glycoproteins	phenotype	located in	cytoplasm	cellular component	PMC4243708	PMC4243708.txt
accumulation of an amorphous unidentified substance	phenotype	caused by	mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
accumulation of an amorphous unidentified substance	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
accumulation of an amorphous unidentified substance	phenotype	caused by	NGLY1	gene	PMC4243708	PMC4243708.txt
accumulation of an amorphous unidentified substance	phenotype	caused by	impaired cytosolic degradation	molecular activity	PMC4243708	PMC4243708.txt
accumulation of an amorphous unidentified substance	phenotype	part of	ERAD process	biological process	PMC4243708	PMC4243708.txt
accumulation of an amorphous unidentified substance	phenotype	located in	cytoplasm	cellular component	PMC4243708	PMC4243708.txt
congenital disorder of glycosylation	phenotype	caused by	mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
congenital disorder of glycosylation	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
congenital disorder of glycosylation	phenotype	caused by	NGLY1	gene	PMC4243708	PMC4243708.txt
congenital disorder of glycosylation	phenotype	caused by	impaired cytosolic degradation	molecular activity	PMC4243708	PMC4243708.txt
congenital disorder of glycosylation	phenotype	part of	ERAD process	biological process	PMC4243708	PMC4243708.txt
congenital disorder of glycosylation	phenotype	located in	cytoplasm	cellular component	PMC4243708	PMC4243708.txt
Exome sequencing	assay	produced by	Duke University	organization	PMC4243708	PMC4243708.txt
Exome sequencing	assay	produced by	University of British Columbia	organization	PMC4243708	PMC4243708.txt
Exome sequencing	assay	produced by	Stanford University	organization	PMC4243708	PMC4243708.txt
Exome sequencing	assay	produced by	Baylor College of Medicine	organization	PMC4243708	PMC4243708.txt
Sanger sequencing of NGLY1	assay	performed in	Patient 4	<other>	PMC4243708	PMC4243708.txt
Sanger sequencing of NGLY1	assay	confirmed by	GeneDx	organization	PMC4243708	PMC4243708.txt
Illumina HiSeq2000	macromolecular complex	used in	Exome sequencing	assay	PMC4243708	PMC4243708.txt
Agilent SureSelect Human All Exon 50 Mb Kit	macromolecular complex	used in	Exome sequencing	assay	PMC4243708	PMC4243708.txt
Complete Genomics	organization	used in	Exome sequencing	assay	PMC4243708	PMC4243708.txt
VCRome2	macromolecular complex	used in	DNA capture-sequencing	assay	PMC4243708	PMC4243708.txt
Illumina HiSeq2000	macromolecular complex	produces	Sequence data	<other>	PMC4243708	PMC4243708.txt
Baylor College of Medicine Whole Genome Laboratory	organization	performed	WES	assay	PMC4243708	PMC4243708.txt
Emory Genetics Laboratory	organization	performed	WES	assay	PMC4243708	PMC4243708.txt
Stanford Institutional Review Board	organization	approved	this study	<other>	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	movement disorder	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hypo- or alacrima	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	abnormal brain imaging	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	EEG abnormalities	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	microcephaly	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	diminished reflexes	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hepatocyte cytoplasmic storage material or vacuolization	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	seizures	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	abnormal nerve conduction	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	premature death	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Global developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Microcephaly	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Hypotonia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Movement disorder	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	EEG abnormalities	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Seizures	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Ocular apraxia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Alacrima/hypolacrima	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Corneal ulcerations/scarring	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Chalazions	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Strabismus	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Lactic acidosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Neonatal jaundice	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Elevated AFP	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Liver fibrosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Liver storage or vacuolization	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Constipation	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Dysmorphic features	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Scoliosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Small hands/feet	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Peripheral neuropathy	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	involuntary movements	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	athetosis involving the trunk and extremities	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	constant lip smacking and pursing while awake	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	mild neonatal jaundice	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	Global developmental delay	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	intractable multifocal epilepsy	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	myoclonic seizures	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	drop attacks	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	staring or tonic episodes	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	liver disease	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	cortical vision loss	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	congenital alacrima	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	corneal ulcerations with scarring	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	central hypotonia	phenotype	PMC4243708	PMC4243708.txt
Patient 1	organism	has phenotype	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	intrauterine growth retardation	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	intention tremor	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	involuntary movements of neck, hands and arm	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	ocular apraxia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	distal tapering of hands and feet	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	diminished deep tendon reflexes	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	cortical vision impairment	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	alacrima	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	dry eyes	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	intellectual disabilities	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	limited expressive speech	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	ambulation with a walker	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	poor feeding	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	lethargy	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	hyperbilirubinemia	phenotype	PMC4243708	PMC4243708.txt
Phototherapy	treatment	treats	hyperbilirubinemia	disease	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	transient thrombocytopenia	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	acquired microcephaly	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	bilateral exotropia	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	constipation	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	intermittent mild lactic acidemia	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	absence of tears when crying	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	intermittent chalazions	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	staring spells	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	extrapyramidal movement disorder	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	asynchronous myoclonic jerks of the limbs and shoulders	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	subtle choreoathetotic movements of the hands and fingers	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	unsteady gait	phenotype	PMC4243708	PMC4243708.txt
Patient 3	organism	has phenotype	communication with vocalizations, gestures and use of a speech-generating device	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	intrauterine growth restriction (IUGR)	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	oligohydramnios	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	mild hyperbilirubinemia	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	intermittent head flexion	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	generalized poly-spike discharges	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	mild tonic seizures	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	symmetric spasms with bilateral arm extension	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	Involuntary movements of the upper extremities	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	bilateral ptosis	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	abnormal tear production	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	constipation	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	recurrent episodes of keratoconjunctivitis	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	poor lid closure during sleep	phenotype	PMC4243708	PMC4243708.txt
Patient 4	organism	has phenotype	corneal scarring	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	constant movements of arms and legs	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	head bobbing	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	liver transaminase elevations	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	diminished reflexes	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	dry eyes	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	microcephaly	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	myoclonic seizures	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	developmental regression	phenotype	PMC4243708	PMC4243708.txt
Patient 5	organism	has phenotype	death following viral illness and prolonged seizure	phenotype	PMC4243708	PMC4243708.txt
lubricant drops	drug	treats	dry eyes	phenotype	PMC4243708	PMC4243708.txt
myoclonic seizures	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
microcephaly	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
dry eyes	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
diminished reflexes	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
liver transaminase elevations	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
head bobbing	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
constant movements of arms and legs	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
global developmental delay	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
developmental regression	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
death following viral illness and prolonged seizure	phenotype	caused by	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	developmental delay	phenotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	microcephaly	phenotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	myopathic- appearing face	phenotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	constant involuntary movements	phenotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	tendency to hyperextend her arms	phenotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	tendency to close her fists	phenotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has phenotype	jaundice	phenotype	PMC4243708	PMC4243708.txt
trisomy 18	genetic variant	associated with	positive second trimester serum screen	assay	PMC4243708	PMC4243708.txt
SLOS	disease	associated with	positive second trimester serum screen	assay	PMC4243708	PMC4243708.txt
Cesarean section	biological process	produces	Patient 6	organism	PMC4243708	PMC4243708.txt
ultrasound	assay	associated with	IUGR	disease	PMC4243708	PMC4243708.txt
phototherapy	treatment	treats	jaundice	disease	PMC4243708	PMC4243708.txt
Patient 6	organism	has attribute	normal female karyotype	genotype	PMC4243708	PMC4243708.txt
Patient 6	organism	has attribute	death at 9 1⁄2 months of age	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	strabismus	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	athetoid arm and hand movements	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	clasped hands	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	Microcephaly	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	severe developmental delay	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	slow progress without regression	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	learned to sit alone	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	started to crawl at 2 years	phenotype	PMC4243708	PMC4243708.txt
Patient 7	organism	has phenotype	no words	phenotype	PMC4243708	PMC4243708.txt
Prenatal screen	assay	associated with	increased risk for trisomy 21	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	mild jaundice	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	strabismus	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	athetoid arm and hand movements	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	clasped hands	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	elevated liver transaminases	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Microcephaly	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	severe developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	slow progress without regression	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	learned to sit alone	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	started to crawl at 2 years	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	no words	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	decreased fetal movement	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	bradycardia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	IUGR	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	cyanosis at birth	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Anal stenosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	movement disorder	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	head bobbing	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	extremity athetosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	Seizures	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	loss of mobility	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	acquired microcephaly	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	inability to close eyes during sleep	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	chronic conjunctivitis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	corneal clouding	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hypolacrima	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	strabismus	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hearing impairment	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	gastro-esophageal reflux	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	chronic constipation	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	severe scoliosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	talipes equinovarus	phenotype	PMC4243708	PMC4243708.txt
c.1201A>T (p.R401X) mutation	genetic variant	associated with	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
c.1201A>T (p.R401X) mutation	genetic variant	has phenotype	mild clinical phenotype	phenotype	PMC4243708	PMC4243708.txt
NGLY1 gene	gene	has genotype	compound heterozygote genotype	genotype	PMC4243708	PMC4243708.txt
NGLY1 gene	gene	produces	Q631S	protein variant	PMC4243708	PMC4243708.txt
NGLY1 gene	gene	produces	R401X	protein variant	PMC4243708	PMC4243708.txt
Q631S	protein variant	located in	transcript ENST00000280700	transcript variant	PMC4243708	PMC4243708.txt
R401X	protein variant	located in	transcript ENST00000280700	transcript variant	PMC4243708	PMC4243708.txt
Q631S	protein variant	causes	nonsense mutation	genetic variant	PMC4243708	PMC4243708.txt
R401X	protein variant	causes	nonsense mutation	genetic variant	PMC4243708	PMC4243708.txt
Patient 2	organism	has genotype	c.1370dupG or p.R458fs	genetic variant	PMC4243708	PMC4243708.txt
NGLY1 gene	gene	has gene product	exon 9	macromolecular complex	PMC4243708	PMC4243708.txt
c.1370dupG or p.R458fs	genetic variant	causes	frame shift in codon 458	phenotype	PMC4243708	PMC4243708.txt
c.1370dupG or p.R458fs	genetic variant	causes	insertion of 13 incorrect residues	phenotype	PMC4243708	PMC4243708.txt
c.1370dupG or p.R458fs	genetic variant	causes	stop codon in exon 9	phenotype	PMC4243708	PMC4243708.txt
c.1370dupG or p.R458fs	genetic variant	not seen in	3321 other subjects at Duke	organism	PMC4243708	PMC4243708.txt
c.1370dupG or p.R458fs	genetic variant	not seen in	6503 subjects on the Exome Variant Server	organism	PMC4243708	PMC4243708.txt
Patient 3	organism	has genotype	Mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
Baylor College of Medicine	organization	produces	WES and whole-genome sequencing	assay	PMC4243708	PMC4243708.txt
Stanford University	organization	produces	WES and whole-genome sequencing	assay	PMC4243708	PMC4243708.txt
G>A mutation at position 3:25761670 (hg19)	genetic variant	causes	p.R542X	protein variant	PMC4243708	PMC4243708.txt
3 base pair in-frame deletion TCC>	genetic variant	located in	position 3:25775416 (hg19)	genetic variant	PMC4243708	PMC4243708.txt
G>T mutation at position 3:25777564	genetic variant	produces	heterozygous SMP	genetic variant	PMC4243708	PMC4243708.txt
NGLY1	gene	has gene product	p.R542X	protein	PMC4243708	PMC4243708.txt
NGLY1	gene	has gene product	heterozygous SMP	protein	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	caused by	Mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
Patient 4	organism	has genotype	p.R401X	genetic variant	PMC4243708	PMC4243708.txt
p.R401X	genetic variant	located in	3:25775422 (hg19)	<other>	PMC4243708	PMC4243708.txt
p.R401X	genetic variant	located in	ENST00000280700	transcript variant	PMC4243708	PMC4243708.txt
p.R401X	genetic variant	located in	c.1201A>T	genetic variant	PMC4243708	PMC4243708.txt
p.R401X	genetic variant	located in	exon 8 of NGLY1	<other>	PMC4243708	PMC4243708.txt
Sanger sequencing	assay	produces	p.R401X	genetic variant	PMC4243708	PMC4243708.txt
Duke University	organization	produces	p.R401X	genetic variant	PMC4243708	PMC4243708.txt
CLIA-certified laboratory	organization	confirms	p.R401X	genetic variant	PMC4243708	PMC4243708.txt
GeneDx	organization	confirms	p.R401X	genetic variant	PMC4243708	PMC4243708.txt
NGLY1	gene	has genotype	single nucleotide variant T> A at position 3:25775422 (hg19)	genetic variant	PMC4243708	PMC4243708.txt
single nucleotide variant T> A at position 3:25775422 (hg19)	genetic variant	causes	R401X	protein variant	PMC4243708	PMC4243708.txt
R401X	protein variant	caused by	base pair substitution	genetic variant	PMC4243708	PMC4243708.txt
Patients 5 and 6	organism	has genotype	single nucleotide variant T> A at position 3:25775422 (hg19)	genetic variant	PMC4243708	PMC4243708.txt
mother of Patients 5 and 6	organism	has genotype	heterozygous call of single nucleotide variant T> A at position 3:25775422 (hg19)	genetic variant	PMC4243708	PMC4243708.txt
NGLY1 variant	genetic variant	validated by	Sanger sequencing	molecular activity	PMC4243708	PMC4243708.txt
Patients 7 and 8	organism	has genotype	R401X	genetic variant	PMC4243708	PMC4243708.txt
R401X	genetic variant	located in	3:25775422 (hg19)	<other>	PMC4243708	PMC4243708.txt
R401X	genetic variant	located in	ENST00000280700	transcript variant	PMC4243708	PMC4243708.txt
R401X	genetic variant	located in	c.1201A>T	genetic variant	PMC4243708	PMC4243708.txt
R401X	genetic variant	located in	exon 8 of NGLY1	<other>	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	abnormal tear production	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	choreoathetosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	liver disease	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	acquired microcephaly	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	hypotonia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	EEG abnormalities	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	brain imaging abnormalities	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	peripheral neuropathy	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	constipation	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	history of IUGR	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	dysmorphic features	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	adrenal cortex vacuolation	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	low uE3	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	part of	ERAD pathway	pathway	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	involved in	cytosolic proteasome	cellular component	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	caused by	knockout mutations in NGLY1	genetic variant	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	adrenal function dysfunction	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	central nervous system	cell type	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	heart	organism	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	liver	organism	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	gastrointestinal tract	organism	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	endocrine system	organism	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	IUGR	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	failure to thrive	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	global developmental delay	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	liver impairment	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	abnormalities detected on brain imaging	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	hypo- or alacrima	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	movement disorder	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	tremulousness	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	varying degrees of choreoathetosis	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	multi-system disease	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	prominent neuromuscular involvement	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	Lactic acidemia	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	not associated with	cerebellar atrophy	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	not associated with	lipodystrophy	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	not associated with	significant heart manifestations	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	not associated with	CDGs	disease	PMC4243708	PMC4243708.txt
Mitochondrial electron transport chain enzymology	biological process	occurs in	skin fibroblasts	cell type	PMC4243708	PMC4243708.txt
Mitochondrial electron transport chain enzymology	biological process	occurs in	muscle	tissue	PMC4243708	PMC4243708.txt
Mitochondrial electron transport chain enzymology	biological process	occurs in	liver	tissue	PMC4243708	PMC4243708.txt
Mitochondrial DNA	macromolecular complex	located in	liver	tissue	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	basal ganglia involvement	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	retinitis pigmentosa	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	cardiomyopathy	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	liver failure	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	renal tubular acidosis	disease	PMC4243708	PMC4243708.txt
Brain disease	disease	has participant	Patients 5 and 6	organism	PMC4243708	PMC4243708.txt
Hypoxic-ischemic encephalopathy	disease	associated with	secondary mitochondrial dysfunction	phenotype	PMC4243708	PMC4243708.txt
Hypoxic-ischemic encephalopathy	disease	associated with	neuronal loss	phenotype	PMC4243708	PMC4243708.txt
Hypoxic-ischemic encephalopathy	disease	associated with	gliosis	phenotype	PMC4243708	PMC4243708.txt
Spongiform degeneration	phenotype	associated with	mitochondrial disorders	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	mitochondrial disorders	disease	PMC4243708	PMC4243708.txt
ERAD pathway	pathway	associated with	Golgi apparatus	cellular component	PMC4243708	PMC4243708.txt
ERAD pathway	pathway	associated with	erlin1/2 complex	macromolecular complex	PMC4243708	PMC4243708.txt
ERAD pathway	pathway	associated with	E3-ubiquitin ligase	protein	PMC4243708	PMC4243708.txt
NGLY1	gene	causes	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
MAN1B1	gene	associated with	non-syndromic autosomal recessive intellectual disability	disease	PMC4243708	PMC4243708.txt
MAN1B1	gene	associated with	subtle dysmorphic features	phenotype	PMC4243708	PMC4243708.txt
α-1,2-Mannosidase	protein	located in	Golgi apparatus	cellular component	PMC4243708	PMC4243708.txt
α-1,2-Mannosidase	protein	participates in	glycoprotein quality control	biological process	PMC4243708	PMC4243708.txt
ERLIN2	gene	causes	intellectual disability	disease	PMC4243708	PMC4243708.txt
ERLIN2	gene	causes	developmental regression	phenotype	PMC4243708	PMC4243708.txt
ERLIN2	gene	causes	multiple contractures	phenotype	PMC4243708	PMC4243708.txt
abnormal erlin2	protein variant	causes	impaired ERAD	phenotype	PMC4243708	PMC4243708.txt
abnormal erlin2	protein variant	disrupts	erlin1/2 complex	macromolecular complex	PMC4243708	PMC4243708.txt
ERLIN2	gene	associated with	hereditary spastic paraplegia	disease	PMC4243708	PMC4243708.txt
IP3 receptors	protein	form	calcium channels	macromolecular complex	PMC4243708	PMC4243708.txt
IP3 receptors	protein	part of	ER membranes	cellular component	PMC4243708	PMC4243708.txt
IP3 receptors	protein	involved in	mammalian cell signaling	biological process	PMC4243708	PMC4243708.txt
IP3 receptors	protein	undergo	rapid degradation	biological process	PMC4243708	PMC4243708.txt
rapid degradation	biological process	part of	ubiquitin-proteasome pathway	pathway	PMC4243708	PMC4243708.txt
RNF170	protein	mediates	ubiquitination and processing of the IP3 receptor	biological process	PMC4243708	PMC4243708.txt
RNF170	protein	interacts with	erlin1/2 complex	macromolecular complex	PMC4243708	PMC4243708.txt
Mutations in RNF170	genetic variant	cause	late- onset autosomal dominant sensory ataxia	disease	PMC4243708	PMC4243708.txt
Abnormal E3-ubiquitin ligase activity	biological process	postulated to play a role in	pathogenesis of an autosomal dominant form of Charcot-Marie-Tooth disease	disease	PMC4243708	PMC4243708.txt
quality control system for targeting and degrading misfolded proteins	biological process	implicated in	neurological conditions	disease	PMC4243708	PMC4243708.txt
NGLY1	protein	located in	cytoplasm	cellular component	PMC4243708	PMC4243708.txt
NGLY1	protein	participates in	proteasomal degradation of aberrant glycoproteins	biological process	PMC4243708	PMC4243708.txt
NGLY1	protein	enables	initial cleavage of bulky N-glycan chains on misfolded glycoproteins	molecular activity	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	accumulation of intact glycoproteins in the cytoplasm	phenotype	PMC4243708	PMC4243708.txt
NGLY1	protein	involved in	proteolysis	biological process	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	accumulation of an amorphous substance in the liver	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	vacuolization	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	liver disease	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	causes	accumulation of misfolded glycoproteins in the cytoplasm	phenotype	PMC4243708	PMC4243708.txt
Transferrin isoelectric focusing	assay	used in	NGLY1-deficient patients	organism	PMC4243708	PMC4243708.txt
mass spectrometry studies	assay	used in	NGLY1-deficient patients	organism	PMC4243708	PMC4243708.txt
NGLY1	gene	plays a role in	maintaining central nervous system integrity	biological process	PMC4243708	PMC4243708.txt
png-1	gene	is allele of	NGLY1	gene	PMC4243708	PMC4243708.txt
Caenorhabditis elegans	organism	has genotype	loss-of-function mutations in png-1	genetic variant	PMC4243708	PMC4243708.txt
loss-of-function mutations in png-1	genetic variant	causes	peripheral nervous system defects	phenotype	PMC4243708	PMC4243708.txt
peripheral nervous system defects	phenotype	associated with	aberrant neuronal branching	phenotype	PMC4243708	PMC4243708.txt
aberrant neuronal branching	phenotype	associated with	peripheral neuropathy	disease	PMC4243708	PMC4243708.txt
peripheral neuropathy	disease	associated with	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	central and peripheral nervous system abnormalities	phenotype	PMC4243708	PMC4243708.txt
c.1201A>T (p.R401X)	genetic variant	associated with	NGLY1	gene	PMC4243708	PMC4243708.txt
homozygous mutations	genetic variant	associated with	p.R401X	protein variant	PMC4243708	PMC4243708.txt
homozygous mutations	genetic variant	causes	severe phenotype	phenotype	PMC4243708	PMC4243708.txt
c.1201A>T (p.R401X)	genetic variant	associated with	disease	disease	PMC4243708	PMC4243708.txt
NGLY1	gene	associated with	NGLY1 deficiency	disease	PMC4243708	PMC4243708.txt
NGLY1	gene	associated with	functional genetic variation	genetic variant	PMC4243708	PMC4243708.txt
functional genetic variation	genetic variant	associated with	human population	organism	PMC4243708	PMC4243708.txt
mutations	genetic variant	associated with	disease	disease	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	elevation of AFP and liver enzymes in infancy	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	relative normalization in early childhood	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	accumulation of a substance with staining properties similar to glycogen in hepatocyte cytoplasm	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	absent tears resulting in blepharitis and corneal ulceration	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	a movement disorder	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	peripheral neuropathy	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	transient nature of the AFP and liver transaminase elevation	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	has phenotype	more mild phenotype	phenotype	PMC4243708	PMC4243708.txt
WES and whole genome sequencing	assay	produces	detection of further cases	phenotype	PMC4243708	PMC4243708.txt
NGLY1 deficiency	disease	associated with	undetected older or more mildly affected individuals	phenotype	PMC4243708	PMC4243708.txt
N-glycanase 1	protein	encoded by	NGLY1	gene	PMC7477955	PMC7477955.txt
N-glycanase 1	protein	involved in	cleavage of the beta-aspartyl glycosylamine bond of N-linked glycoproteins	biological process	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	optic atrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	retinal pigmentary changes/cone dystrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	delayed bone age	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	joint hypermobility	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	lower than predicted resting energy expenditure	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	low CSF total protein and albumin	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	high antibody titers towards rubella and/or rubeola following vaccination	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	decreased tear production	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	transient transaminitis	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	small feet	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	complex hyperkinetic movement disorder	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	global developmental delay with relatively preserved socialization	phenotype	PMC7477955	PMC7477955.txt
NGLY1	gene	associated with	Deglycosylation	biological process	PMC7477955	PMC7477955.txt
NGLY1	gene	associated with	glycosylation	biological process	PMC7477955	PMC7477955.txt
NGLY1	gene	associated with	NGLY1-CDDG	disease	PMC7477955	PMC7477955.txt
NGLY1	gene	associated with	congenital disorder of glycosylation	disease	PMC7477955	PMC7477955.txt
NGLY1	gene	associated with	N-linked glycosylation	biological process	PMC7477955	PMC7477955.txt
NGLY1	gene	has phenotype	phenotype	phenotype	PMC7477955	PMC7477955.txt
NGLY1	gene	associated with	human	organism	PMC7477955	PMC7477955.txt
Congenital disorders of glycosylation	disease	has attribute	abnormalities in the process of glycosylation of biomolecules	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	caused by	biallelic mutations in the NGLY1 gene	genetic variant	PMC7477955	PMC7477955.txt
Need et al.	organization	produces	exome sequencing	assay	PMC7477955	PMC7477955.txt
exome sequencing	assay	identifies	biallelic mutations in the NGLY1 gene	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 gene	gene	has genotype	biallelic mutations	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	instance of	congenital disorder of de-glycosylation	disease	PMC7477955	PMC7477955.txt
NGLY1	gene	encodes	N-glycanase 1	protein	PMC7477955	PMC7477955.txt
N-glycanase 1	protein	involved in	cytosolic degradation of misfolded glycoproteins	biological process	PMC7477955	PMC7477955.txt
N-glycanase 1	protein	involved in	degradation of other glycoproteins	biological process	PMC7477955	PMC7477955.txt
3-year-old male	organism	has genotype	c.1891delC (p.Q631S NM_018297.3) variant	genetic variant	PMC7477955	PMC7477955.txt
3-year-old male	organism	has genotype	c.1201A>T (p.R401* NM_018297.3) variant	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 protein	protein	expressed in	leukocytes	cell type	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has participant	Transferrin isoelectric focusing	assay	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has participant	N-glycan profiling	assay	PMC7477955	PMC7477955.txt
social media campaign	<other>	identified	additional affected individuals	organism	PMC7477955	PMC7477955.txt
Enns et al.	organization	published	retrospective chart review	<other>	PMC7477955	PMC7477955.txt
National Institutes of Health (NIH) Clinical Center	organization	initiated	natural history study of the disorder	clinical trial	PMC7477955	PMC7477955.txt
National Institutes of Health (NIH) Clinical Center	organization	performed	laboratory investigations	assay	PMC7477955	PMC7477955.txt
National Institutes of Health (NIH) Clinical Center	organization	performed	clinical investigations	assay	PMC7477955	PMC7477955.txt
National Institutes of Health (NIH) Clinical Center	organization	performed	radiologic investigations	assay	PMC7477955	PMC7477955.txt
National Institutes of Health (NIH) Clinical Center	organization	performed	investigations on 12 affected individuals	<other>	PMC7477955	PMC7477955.txt
NIH protocol #76-HG-0238	clinical trial	has participant	Inborn Errors of Metabolism	disease	PMC7477955	PMC7477955.txt
NIH protocol #76-HG-0238	clinical trial	has participant	Other Genetic Disorders	disease	PMC7477955	PMC7477955.txt
NIH protocol #14-HG-0071	clinical trial	has participant	Congenital Disorders of Glycosylation	disease	PMC7477955	PMC7477955.txt
National Human Genome Research Institute’s Institutional Review Board	organization	produces	NIH protocol #76-HG-0238	clinical trial	PMC7477955	PMC7477955.txt
National Human Genome Research Institute’s Institutional Review Board	organization	produces	NIH protocol #14-HG-0071	clinical trial	PMC7477955	PMC7477955.txt
NIH Clinical Center	organization	has participant	each subject	<other>	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	Blood	biological process	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	urine	biological process	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	cerebral spinal fluid	biological process	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	lymphoblasts	cell type	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	primary dermal fibroblasts	cell type	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	brain magnetic resonance imaging and spectroscopy	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	electroencephalograms	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	electromyogram	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	nerve conduction studies	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	indirect calorimetry	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	eye examination with Schirmer II testing	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	optical coherence tomography scans and electroretinography	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	behavioral determination of pure tone thresholds	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	tympanometry	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	distortion product otoacoustic emissions	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	auditory brainstem evoked potentials	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	quantitative sweat analysis autonomic testing	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	gastric aspiration	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	swallow study	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	skeletal survey	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	bone age	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	dual X-ray absorptiometry	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	abdominal ultrasound	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	vibration controlled transient elastography	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	echocardiogram	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	electrocardiogram	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	clinical neurology	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	audiology	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	nutrition	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	ophthalmology	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	hepatology	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	growth, puberty and hormonal studies	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	allergy and immunology	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	genetic counseling	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	physiatry	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	speech, occupational, and physical therapy	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	developmental psychological evaluations	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	Vineland Adaptive Behavior Scales, 2nd edition	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	Cognitive function testing	assay	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has participant	Nijmegen pediatric CDG rating scale	assay	PMC7477955	PMC7477955.txt
NGLY1	gene	has genotype	biallelic mutations	genetic variant	PMC7477955	PMC7477955.txt
biallelic mutations in NGLY1	genetic variant	causes	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has participant	Twelve individuals	organism	PMC7477955	PMC7477955.txt
Twelve individuals	organism	has phenotype	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
c.1201A>T (p.R401*)	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NGLY1	gene	has gene product	catalytic domain	protein	PMC7477955	PMC7477955.txt
catalytic domain	protein	part of	NGLY1	gene	PMC7477955	PMC7477955.txt
NGLY1	gene	has genotype	13 different mutations	genetic variant	PMC7477955	PMC7477955.txt
13 different mutations	genetic variant	part of	NGLY1	gene	PMC7477955	PMC7477955.txt
NGLY1	gene	has genotype	five missense mutations	genetic variant	PMC7477955	PMC7477955.txt
five missense mutations	genetic variant	part of	NGLY1	gene	PMC7477955	PMC7477955.txt
NGLY1	gene	has genotype	five nonsense mutations	genetic variant	PMC7477955	PMC7477955.txt
five nonsense mutations	genetic variant	part of	NGLY1	gene	PMC7477955	PMC7477955.txt
NGLY1	gene	has genotype	two splice site mutations	genetic variant	PMC7477955	PMC7477955.txt
two splice site mutations	genetic variant	part of	NGLY1	gene	PMC7477955	PMC7477955.txt
NGLY1	gene	has genotype	one frameshift mutation	genetic variant	PMC7477955	PMC7477955.txt
one frameshift mutation	genetic variant	part of	NGLY1	gene	PMC7477955	PMC7477955.txt
NGLY1	gene	has genotype	four mutations in the catalytic domain	genetic variant	PMC7477955	PMC7477955.txt
four mutations in the catalytic domain	genetic variant	part of	NGLY1	gene	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.953T>C	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.1169G>C	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.1201A>T	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.931G>A	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.730T>C	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.1604G>A	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.1910delT	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.1891delC	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.622C>T	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.930C>T	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.347C>G	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.881+5G>T	genetic variant	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has genotype	c.1370dupG	genetic variant	PMC7477955	PMC7477955.txt
c.1201A>T	genetic variant	associated with	rs201337954	<other>	PMC7477955	PMC7477955.txt
c.931G>A	genetic variant	associated with	rs201791209	<other>	PMC7477955	PMC7477955.txt
c.1891delC	genetic variant	associated with	rs587776982	<other>	PMC7477955	PMC7477955.txt
c.622C>T	genetic variant	associated with	rs200561967	<other>	PMC7477955	PMC7477955.txt
c.1370dupG	genetic variant	associated with	rs587777265	<other>	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hypotonic facies	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	low weight	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	thin facies	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hollowed cheeks	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	visible zygomatic arches	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	poor growth after mid-childhood	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	acquired microcephaly	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	total foot length < 3rd percentile	phenotype	PMC7477955	PMC7477955.txt
Nijmegen Scores	phenotype	associated with	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
c.1201A>T	genetic variant	associated with	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
c.930C>T	genetic variant	associated with	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
c.622C>T	genetic variant	associated with	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
c.1201A>T	genetic variant	correlated with	disease severity	phenotype	PMC7477955	PMC7477955.txt
c.930C>T	genetic variant	correlated with	mild impairment	phenotype	PMC7477955	PMC7477955.txt
c.622C>T	genetic variant	correlated with	mild impairment	phenotype	PMC7477955	PMC7477955.txt
males	organism	has phenotype	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
females	organism	has phenotype	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	developmental delay	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	intellectual disability	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	profound intellectual disability	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Motor deficits	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	impaired Daily Living Skills scores	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	below average IQ	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	nonverbal communication	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	single word speech	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	phrase speech	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	strong Socialization scores	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Communication scores	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Daily Living Skills scores	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Vineland Adaptive Behavior Composite scores	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	clinical seizures	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	subclinical seizures	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	multifocal epileptiform activity	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hyperkinetic movement disorders	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	choreiform movements	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	athetoid movements	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	dystonic movements	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	myoclonic movements	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	action tremor	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	dysmetric movements	phenotype	PMC7477955	PMC7477955.txt
Brain MRI and MRS	assay	has participant	Eleven individuals	organism	PMC7477955	PMC7477955.txt
Delayed myelination	phenotype	occurs in	three of the four youngest individuals	organism	PMC7477955	PMC7477955.txt
Cerebral atrophy	phenotype	occurs in	Six of nine individuals	organism	PMC7477955	PMC7477955.txt
Cerebellar atrophy	phenotype	occurs in	Four individuals (#1, #2, #6, #10)	organism	PMC7477955	PMC7477955.txt
Atrophy	phenotype	correlated with	age	<other>	PMC7477955	PMC7477955.txt
Atrophy	phenotype	correlated with	worsening of all functional measurements	phenotype	PMC7477955	PMC7477955.txt
Brain volume	phenotype	correlated with	CSF levels of 5-HIAA	chemical substance	PMC7477955	PMC7477955.txt
Brain volume	phenotype	correlated with	tetrahydrobiopterin	chemical substance	PMC7477955	PMC7477955.txt
Brain volume	phenotype	correlated with	5-HVA	chemical substance	PMC7477955	PMC7477955.txt
N-acetylaspartylglutamate + N-acetylaspartate	metabolite	decreases abundance of	left centrum semiovale	cellular component	PMC7477955	PMC7477955.txt
N-acetylaspartylglutamate + N-acetylaspartate	metabolite	decreases abundance of	midline parietal grey matter	cellular component	PMC7477955	PMC7477955.txt
N-acetylaspartylglutamate + N-acetylaspartate	metabolite	decreases abundance of	superior cerebellar vermis	cellular component	PMC7477955	PMC7477955.txt
glutamine + glutamate + gamma-aminobutyric acid	metabolite	decreases abundance of	midline parietal grey matter	cellular component	PMC7477955	PMC7477955.txt
glutamine + glutamate + gamma-aminobutyric acid	metabolite	decreases abundance of	left centrum semiovale	cellular component	PMC7477955	PMC7477955.txt
glutamine + glutamate + gamma-aminobutyric acid	metabolite	decreases abundance of	pons	cellular component	PMC7477955	PMC7477955.txt
Choline	metabolite	increases abundance of	left centrum semiovale	cellular component	PMC7477955	PMC7477955.txt
myo-inositol	metabolite	increases abundance of	pons	cellular component	PMC7477955	PMC7477955.txt
age	phenotype	correlated with	MRS-measured metabolites	metabolite	PMC7477955	PMC7477955.txt
functional assessments	phenotype	correlated with	MRS-measured metabolites	metabolite	PMC7477955	PMC7477955.txt
brain volume	phenotype	correlated with	MRS-measured metabolites	metabolite	PMC7477955	PMC7477955.txt
neurotransmitters in the CSF	metabolite	correlated with	MRS-measured metabolites	metabolite	PMC7477955	PMC7477955.txt
atrophy	phenotype	correlated with	total CSF protein	protein	PMC7477955	PMC7477955.txt
MRS metabolite measurements	metabolite	not correlated with	total CSF protein	protein	PMC7477955	PMC7477955.txt
MRS metabolite measurements	metabolite	not correlated with	CSF albumin	protein	PMC7477955	PMC7477955.txt
MRS metabolite measurements	metabolite	not correlated with	CSF/serum albumin ratio	<other>	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	CSF total protein and albumin concentrations	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	CSF/serum albumin ratios	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	CSF 5-hydroxyindolacetic acid (5-HIAA)	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	homovanillic acid (HVA)	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	neuronal loss	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	Neopterin levels	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	CSF tetrahydrobiopterin (BH4) levels	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	brain atrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	CSF lactate and amino acid levels	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	CSF leucocyte counts	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	glucose concentrations	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	3-O-methyldopa concentrations	chemical substance	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	5-methyltetrahydrofolate concentrations	chemical substance	PMC7477955	PMC7477955.txt
Nerve conduction studies	assay	has participant	individuals	organism	PMC7477955	PMC7477955.txt
axonal sensorimotor polyneuropathy	disease	has phenotype	demyelinative features	phenotype	PMC7477955	PMC7477955.txt
neurophysiological testing	assay	demonstrates	loss of sensory and motor axons	phenotype	PMC7477955	PMC7477955.txt
neurophysiological testing	assay	demonstrates	sympathetic nerve function	phenotype	PMC7477955	PMC7477955.txt
neurophysiological testing	assay	demonstrates	abnormalities in myelination of peripheral nerves	phenotype	PMC7477955	PMC7477955.txt
neurophysiological testing	assay	demonstrates	motor neuron degeneration	phenotype	PMC7477955	PMC7477955.txt
individual #6	organism	has phenotype	progression of the neuropathy	phenotype	PMC7477955	PMC7477955.txt
needle EMG	assay	has participant	subjects	organism	PMC7477955	PMC7477955.txt
NCS results	assay	associated with	neurogenic findings	phenotype	PMC7477955	PMC7477955.txt
NCS results	assay	associated with	acute and chronic changes	phenotype	PMC7477955	PMC7477955.txt
QSWEATs	assay	associated with	axonal sensorimotor neuropathies	disease	PMC7477955	PMC7477955.txt
distal lower extremity QSWEAT	assay	associated with	length dependent neuropathy	disease	PMC7477955	PMC7477955.txt
tibial motor amplitude	phenotype	negatively correlated with	age	<other>	PMC7477955	PMC7477955.txt
tibial motor amplitude	phenotype	decreases abundance of	amplitude	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Lagophthalmous	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	ptosis	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	exotropia	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	esotropia	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	corneal neovascularization	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	pannus formation	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	scarring	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	optic nerve pallor	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	atrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	retinal	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	pigmentary changes	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	blonde or poorly pigmented retinal periphery	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	refractive errors	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hypo- or complete alacrima	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	cone dystrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	reduced photopic responses	phenotype	PMC7477955	PMC7477955.txt
Audiologic assessments	assay	has participant	11 subjects	organism	PMC7477955	PMC7477955.txt
Behavioral hearing thresholds	phenotype	has attribute	normal hearing sensitivity	phenotype	PMC7477955	PMC7477955.txt
Tympanometry	assay	has attribute	unremarkable	<other>	PMC7477955	PMC7477955.txt
auditory brainstem	cellular component	has attribute	dyssynchronous and/or absent transmission	phenotype	PMC7477955	PMC7477955.txt
auditory brainstem	cellular component	has attribute	increased severity of transmission abnormality with increasing age	phenotype	PMC7477955	PMC7477955.txt
8th nerve	cellular component	has attribute	dyssynchronous and/or absent transmission	phenotype	PMC7477955	PMC7477955.txt
8th nerve	cellular component	has attribute	bilateral involvement in the 4 oldest individuals	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	dyssynchronous and/or absent transmission through the auditory brainstem and/or 8th nerve	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Oral motor deficits	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Premature spillage	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	pharyngeal swallow response delays	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Developmental delays in mastication	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Generalized weakness of the lips and tongue	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Dystonic movements of the tongue	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	persistent oral reflexes of suckling and suck/swallows	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	unremarkable Echocardiograms	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	heart rates in the low 100s	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	QTcB >440 ms	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	normal QTcF	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	obstructive sleep apnea	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	central sleep apnea	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	combined obstructive and central sleep apnea	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	frequent periodic limb movements	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	Gastric pH alteration	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	constipation	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	abnormal abdominal ultrasound	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	possible liver fibrosis	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	altered resting energy expenditure	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	elevated aspartate aminotransferase	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	elevated alanine transaminase	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hepatocellular carcinoma	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	low total cholesterol	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	low LDL	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	low triglycerides	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	unremarkable complete blood counts	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	lymphoblasts	cell type	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	acute lymphocytic leukemia	disease	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	normal prothrombin time	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	normal partial thromboplastin time	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	normal international normalized ratio	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	low protein C activity	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	low Factor II activity	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	low Factor IX	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	low Factor XI	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	low fibrinogen	phenotype	PMC7477955	PMC7477955.txt
c.1201A>T mutation	genetic variant	associated with	lower Factor II	phenotype	PMC7477955	PMC7477955.txt
c.1201A>T mutation	genetic variant	associated with	lower Factor IX	phenotype	PMC7477955	PMC7477955.txt
c.1201A>T mutation	genetic variant	associated with	lower Factor XI	phenotype	PMC7477955	PMC7477955.txt
c.1201A>T mutation	genetic variant	associated with	Antithrombin III	protein	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	out of range elevations in antibody titers towards rubella and/or rubeola	phenotype	PMC7477955	PMC7477955.txt
MMR vaccination	biological process	causes	out of range elevations in antibody titers towards rubella and/or rubeola	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	associated with	abnormal biochemical markers in mitochondropathies and hypoglycosylation disorders	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	delayed bone age	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	low femoral bone density	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	joint hypermobility	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	contractures in both small and large joints	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	coxa valga	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	scoliosis	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	growth arrest lines	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	metaphyseal banding	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	dislocations or subluxations involving the hips and shoulder joints	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	sclerosis of the phalanges or tarsal bones	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	flexion deformity of the fingers	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hallux valgus	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	sclerotic lesion of the distal femur	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	thinning of the fibulas	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	prominent apophyseal bone formation in the ileac crests and ischia	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	ulnar bowing	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	expansion of the cortexes in the proximal and middle phalanges in digits 2–4	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	widened phalanges	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	shortened and widened metatarsals	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	low CSF total protein	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	low albumin	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	optic atrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	retinal pigmentary changes	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	cone dystrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	poor weight gain	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	lower than predicted resting energy expenditure	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	central sleep apnea	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	obstructive sleep apnea	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	delayed bone age	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	joint hypermobility	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	progressive brain atrophy	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	abnormalities in brain MRS-measured metabolites	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	abnormalities on skeletal survey	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	high antibody titers after rubella and rubeola vaccination	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	low levels of several pro- and anti- coagulation factors	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	normal Echocardiograms	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	normal electrocardiograms	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	normal CSF lactate levels	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	global developmental delay	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	movement disorder	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	frequent seizure disorder	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	hypotonia	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	hypolacrima or alacrima	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	corneal disease	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	ptosis	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	lagophthalmous	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	strabismus	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	peripheral neuropathy	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	diminished reflexes	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	hypohidrosis	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	auditory brainstem response abnormalities	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	abnormal brain imaging	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	scoliosis	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	acquired microcephaly	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	small hands and feet	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	dysmorphic features	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	constipation	symptom	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	elevated liver enzymes	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	osteopenia	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	hypocholesterolemia	disease	PMC7477955	PMC7477955.txt
liver biopsy specimens	biological process	produces	minimal fibrosis	phenotype	PMC7477955	PMC7477955.txt
liver biopsy specimens	biological process	does not produce	abnormal storage material	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	not associated with	ocular apraxia	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	developmental delay/intellectual disability	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	hyperkinetic movement disorder	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	hypolacrima	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	associated with	elevated transaminases	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	auditory neural pathway dysfunction	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hypohidrosis	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	hypo-lacrima	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	has phenotype	disordered mastication	phenotype	PMC7477955	PMC7477955.txt
auditory neural pathway dysfunction	phenotype	causes	difficulty hearing in the presence of background noise	symptom	PMC7477955	PMC7477955.txt
hypohidrosis	phenotype	causes	core body hyperthermia	symptom	PMC7477955	PMC7477955.txt
hypo-lacrima	phenotype	causes	secondary complications that can impact vision	symptom	PMC7477955	PMC7477955.txt
disordered mastication	phenotype	causes	need for oral motor and swallowing therapies	symptom	PMC7477955	PMC7477955.txt
Motor Skills scores	phenotype	associated with	Daily Living Skills scores	phenotype	PMC7477955	PMC7477955.txt
motor deficits	phenotype	part of	NGLY1-CDDG	disease	PMC7477955	PMC7477955.txt
hyperkinetic movement disorder	phenotype	part of	NGLY1-CDDG	disease	PMC7477955	PMC7477955.txt
myoclonic seizures	phenotype	contributes to	movement disorder	phenotype	PMC7477955	PMC7477955.txt
neurotransmitter deficiency	phenotype	contributes to	movement disorder	phenotype	PMC7477955	PMC7477955.txt
peripheral neuropathy	phenotype	manifestation of	sensory ataxia	phenotype	PMC7477955	PMC7477955.txt
brain atrophy	phenotype	correlated with	functional assessments	<other>	PMC7477955	PMC7477955.txt
loss of neurons	biological process	contributes to	functional impairment	phenotype	PMC7477955	PMC7477955.txt
brain atrophy	phenotype	correlated with	CSF metabolites	metabolite	PMC7477955	PMC7477955.txt
CSF metabolites	metabolite	associated with	damage to neurotransmitter producing neurons	biological process	PMC7477955	PMC7477955.txt
brain atrophy	phenotype	causes	biochemical abnormalities	phenotype	PMC7477955	PMC7477955.txt
NAA	chemical substance	decreases abundance of	functional impairment	phenotype	PMC7477955	PMC7477955.txt
NAA	chemical substance	decreases abundance of	age	<other>	PMC7477955	PMC7477955.txt
choline	chemical substance	increases abundance of	functional impairment	phenotype	PMC7477955	PMC7477955.txt
choline	chemical substance	increases abundance of	age	<other>	PMC7477955	PMC7477955.txt
myo-inositol	chemical substance	increases abundance of	functional impairment	phenotype	PMC7477955	PMC7477955.txt
myo-inositol	chemical substance	increases abundance of	age	<other>	PMC7477955	PMC7477955.txt
creatine	chemical substance	increases abundance of	functional impairment	phenotype	PMC7477955	PMC7477955.txt
creatine	chemical substance	increases abundance of	age	<other>	PMC7477955	PMC7477955.txt
creatine	chemical substance	negatively correlated with	myoinositol	chemical substance	PMC7477955	PMC7477955.txt
NAA	chemical substance	positively correlated with	neurotransmitter levels	<other>	PMC7477955	PMC7477955.txt
NAA	chemical substance	decreases abundance of	neurons	cell type	PMC7477955	PMC7477955.txt
choline	chemical substance	increases abundance of	glial cells	cell type	PMC7477955	PMC7477955.txt
myo-inositol	chemical substance	increases abundance of	gliosis	phenotype	PMC7477955	PMC7477955.txt
creatine	chemical substance	increases abundance of	glial cells	cell type	PMC7477955	PMC7477955.txt
glial cells	cell type	increases abundance of	NGLY1-CDDG individuals	organism	PMC7477955	PMC7477955.txt
neurons	cell type	decreases abundance of	NGLY1-CDDG individuals	organism	PMC7477955	PMC7477955.txt
imbalance	<other>	contributes to	severity of the phenotype	phenotype	PMC7477955	PMC7477955.txt
impaired sweat response	phenotype	associated with	small fiber neuropathy	disease	PMC7477955	PMC7477955.txt
QAlb	biological process	is marker for	blood-CSF barrier dysfunction	disease	PMC7477955	PMC7477955.txt
decreased CSF protein and albumin concentrations	phenotype	is marker for	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	low cholesterol	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	hepatopathy	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	peripheral neuropathy	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	retinal and optic nerve abnormalities	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	seizures	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	developmental delay with socialization as a relative strength	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	delayed bone age	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	hypolacrima	phenotype	PMC7477955	PMC7477955.txt
N-glycanase 1	protein	enables	the cleavage of the amide bond between the proximal N-acetylglucosamine residue of glycans and the asparagine residue of the protein	molecular activity	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	impairment of glycan recycling	biological process	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	hypoglycosylation	biological process	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	abnormalities in transferrin and ApoC-III glycosylation	phenotype	PMC7477955	PMC7477955.txt
misfolded glycoproteins	protein	processed through	endoplasmic reticulum associated degradation pathway	pathway	PMC7477955	PMC7477955.txt
N-glycanase	protein	is part of	degradation of these molecules	biological process	PMC7477955	PMC7477955.txt
ERAD dysfunction	phenotype	contributes to	NGLY1-CDDG phenotype	disease	PMC7477955	PMC7477955.txt
ER-stress	phenotype	occurs in	mouse embryonic fibroblasts	cell type	PMC7477955	PMC7477955.txt
NGLY1-CDDG patient fibroblasts	cell type	expresses	standard ERAD marker	protein	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	progressive disorder	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	worsening function with age	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	peripheral neuropathy	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	auditory neural dysfunction	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	scoliosis	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	inability to maintain weight	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	brain atrophy	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	abnormalities in brain metabolites	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	changes in CSF neurotransmitter levels	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	hypolacrima	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	hepatopathy	disease	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	causes	hyperkinetic movement disorder	disease	PMC7477955	PMC7477955.txt
brain volume	biological process	derives from	NGLY1-CDDG	disease	PMC7477955	PMC7477955.txt
choline levels on MRS	biological process	derives from	NGLY1-CDDG	disease	PMC7477955	PMC7477955.txt
nerve conduction velocities and amplitudes	biological process	derives from	NGLY1-CDDG	disease	PMC7477955	PMC7477955.txt
auditory brainstem evoked responses	biological process	derives from	NGLY1-CDDG	disease	PMC7477955	PMC7477955.txt
NGLY1 mutations	genetic variant	located in	exons	cellular component	PMC7477955	PMC7477955.txt
c.1624C>T	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
c.1205_1207delGAA	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
c.1533_1536delTCAA	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
c.730T>C	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
c.953T>C	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
c.931G>A	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
c.930C> T	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
catalytic domain	macromolecular complex	has participant	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.931G>A	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.1604G>A	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.622C>T	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.347C>G	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.1169G>C	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.730T>C	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.1910delT	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.930C>T	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
NM_018297.3:c.881+5G>T	genetic variant	part of	NGLY1 mutations	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259179	organization	has output	NM_018297.3:c.931G>A	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259180	organization	has output	NM_018297.3:c.1604G>A	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259181	organization	has output	NM_018297.3:c.622C>T	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259182	organization	has output	NM_018297.3:c.347C>G	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259183	organization	has output	NM_018297.3:c.1169G>C	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259184	organization	has output	NM_018297.3:c.730T>C	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259185	organization	has output	NM_018297.3:c.1910delT	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259186	organization	has output	NM_018297.3:c.930C>T	genetic variant	PMC7477955	PMC7477955.txt
ClinVar: SCV000259187	organization	has output	NM_018297.3:c.881+5G>T	genetic variant	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	upturned nasal tip	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	hypotonic facies	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	ptosis	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	brachycephaly	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	thinned facies	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	hollowed cheeks	phenotype	PMC7477955	PMC7477955.txt
NGLY1-CDDG	disease	has phenotype	visible zygomatic arches	phenotype	PMC7477955	PMC7477955.txt
Brain MRI findings	phenotype	has participant	White matter lesions	phenotype	PMC7477955	PMC7477955.txt
White matter lesions	phenotype	located in	two of eleven individuals	organism	PMC7477955	PMC7477955.txt
White matter lesions	phenotype	located in	periventricular white matter	cellular component	PMC7477955	PMC7477955.txt
Cerebral atrophy	phenotype	manifestation of	NGLY1 deficiency	disease	PMC7477955	PMC7477955.txt
Cerebral atrophy	phenotype	produced by	T2-weighting	assay	PMC7477955	PMC7477955.txt
Sulci	cellular component	has attribute	slightly prominent	phenotype	PMC7477955	PMC7477955.txt
Ventricles	cellular component	has attribute	prominent	phenotype	PMC7477955	PMC7477955.txt
Cerebellar tonsils	cellular component	has attribute	high position	phenotype	PMC7477955	PMC7477955.txt
Foramen of Magendie	cellular component	has attribute	large	phenotype	PMC7477955	PMC7477955.txt
Cisterna magna	cellular component	has attribute	large	phenotype	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	causes	conjunctival injection	symptom	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	causes	limbal neovascularization	symptom	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	causes	corneal scarring	symptom	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	causes	severe dry eyes	symptom	PMC7477955	PMC7477955.txt
NGLY1 deficiency	disease	causes	lagophthalmous	symptom	PMC7477955	PMC7477955.txt
